The advent of each new antibiotic is not an unmixed blessing. The advantage of acquiring another agent whose range of antibacterial activity parallels that of already existing antibiotics is somewhat offset by the necessity of re-evaluating the known in the light of the new unknown. And involved is not just the effectiveness of one agent versus another, but the relative cost, potential toxicity, and inherent capacity to induce resistance of each.
The following is a brief summary of the present status of antibiotic therapy. In addition to a table listing the drugs of choice for systemic use against the micro-organisms most commonly involved in clinical infections, it includes a brief discussion of the principles underlying antibiotic treatment based on experimental findings. It is neither a review of the literature nor a handy compendium of drug dosages but rather represents current experience and thinking in a field in which the author has been working for a number of years.
Systemic Use
The antibiotics of choice for the treatment of infections are presented in the table. When two antibiotics are of equal effectiveness, they are so listed.
In general, it will be noted that penicillin is still the drug of choice in most infections caused by gram positive organisms, both coccal and bacillary, whereas infections caused by gram negative bacteria are best treated by streptomycin, aureomycin, or terramycin. The group of Neisseria and the spirochete of syphilis represent notable exceptions to this generalization, penicillin being still the most effective antibiotic against these gram negative organisms.
Chloromycetin (chloramphenicol), like aureomycin and terramycin, is a broad spectrum antibiotic highly effective in a variety of infections but because of its alleged tendency to produce blood dyscrasias it has dropped perhaps unjustifiably into third place (effective but perhaps toxic) in most instances. Where indicated in severe infection, however, it should be used, provided the risk to life from the infection outweighs the risk of possible toxicity.
Polymyxin B is one of the most active antibiotics in vitro against gram negative bacteria but because of its potential nephrotoxicity, its systemic use has been severely limited, possibly unduly so. Recent reports would indicate that polymyxin was not only the drug of choice in a series of cases of enteric and urinary tract infections, notably those due to Pseudomonas aeruginosa, but that in the children treated, it showed very little evidence of renal toxicity. This is confirmed by the author's experience in observing a small series of premature infants with pseudomonas infections. Polymyxin was not only efficacious in treatment, but in no instance did it produce any renal toxic effects.
Neomycin and bacitracin are poorly absorbed agents that have not been recommended for systemic use because of their toxicity. Yet they too, like polymyxin, are beginning to find wider favor for oral use against certain enteric infections because, taken orally, neither one produces significant side reactions. Neomycin has been found to be an excellent intestinal antiseptic since it is quite active against both gram positive and gram negative bacteria. Bacitracin exerts its effect primarily against gram positive enterococci and clostridia.
Erythromycin, one of the newer antibiotics, shows a wide range of activity against many gram positive pathogens and a few gram negative ones. It seems relatively non-toxic and since it is active against many staphylococci and streptococci that are resistant to other antibiotics, it should prove to be a valuable addition to the broad spectrum antibiotics.
Streptomycin still leads the field as a tuberculostatic drug, and it combines well with other antibiotics for other infections. In tuberculous infections, the combined use of streptomycin and para-aminosalicylic acid or nicotinic acid derivatives or both is not only desirable therapeutically but tends also to reduce the hazard of eighth nerve damage (by reducing the dosage of streptomycin) and the risk of development of streptomycin resistance.
In severe infections, combinations of antibiotics are sometimes indicated. In subacute bacterial endocarditis, for example, an adequate combination of penicillin and streptomycin (gram positive infecting organism) or streptomycin and aureomycin (gram negative infecting organism) may turn the tide when any of these agents alone will not. Unfortunately, combinations of antibiotics may result in antagonistic as well as synergistic effects. If penicillin, streptomycin, neomycin, and bacitracin are considered as one group (A) and aureomycin, chloramphenicol and terramycin as another (B), then the members of group A tend to act synergistically towards each other but antagonistically towards members of group B. Group B agents tend to potentiate each other but to behave antagonistically if combined with agents in group A. So, although the last word has not been said, it would seem advisable to avoid combinations of antibiotics when one alone is effective and to use only combinations that have been proved to be effective against infections clinically. Topical Use Neomycin topically is the antibiotic of choice against nearly all pyogenic infections of the skin, mucous membranes, and eyes. It has a very wide range of activity against both gram positive and gram negative organisms and it rarely induces hypersensitivity.
Bacitracin has an antibiotic range roughly similar to penicillin but, unlike penicillin, it maintains its activity in mixed infections and it is essentially non-sensitizing. It is an excellent agent for treating local skin infections caused by staphylococci and streptococci.
Polymyxin B is probably the drug of choice for topical use against pseudomonas infections.
Broad spectrum antibiotics, although effective topically, should, by and large, be reserved for systemic use in order to reduce the risk of inducing hypersensitivity.
Prophylactic Use As the range of effectiveness of antibiotics against infections has been increased by the discovery of new agents, so too has the use of antibiotics in the prophylaxis of infections.
Topically, penicillin is of value for the routine prophylaxis of gonorrheal opthalmia.
In closed communities, penicillin, given by mouth, is useful in the prevention of hemolytic streptococcal or meningococcal infections.
Small daily doses of oral penicillin have been found to be very effective in the prevention of recurrences of rheumatic fever. (The same is true of sulfadiazine.) In the rheumatic subject, the intramuscular administration of procaine penicillin before and after the extraction of teeth, the removal of tonsils, or for that matter any operative procedure around the nose or throat, aids materially in preventing the development of subacute bacterial endocarditis.
The risk of infection after certain "clean" operations, for example, corrective orthopedic surgery, is much decreased by the prophylactic use of antibiotics. In established infections in which surgical interference is indicated, the proper use of antibiotics greatly facilitates the control of the postoperative spread of micro-organisms.
Use and Misuse If chosen and administered intelligently, antibiotics can be depended upon to produce maximal therapeutic effects with minimal adverse side reactions. In addition to selecting with care the drug of choice for each particular infection, it is necessary to keep in mind a few basic principles governing the administration of these agents.
Antibiotics should be given in large enough doses and for a long enough time to control the infection. Inadequate treatment is worse than no treat-ment at all because it permits the emergence of drug resistant variants of the infecting micro-organism. With certain antibiotics, such as streptomycin, resistant variants are prone to appear rapidly. Even with those agents less apt to give rise to resistant forms, the problem is always potentially there and as time goes on, more and more micro-organisms are appearing which seem to be resistant on primary isolation to certain antibiotics. Cross resistance, too, has become an ever-increasing problem. Organisms readily develop mutual cross resistance to aureomycin, terramycin, and chloramphenicol, and there is some evidence to show that resistance to streptomycin is paralleled by resistance to neomycin. In treating an infection that has become resistant to one antibiotic, the possibility of cross resistance should be kept in mind in choosing another agent.
Overly prolonged therapy is just as unwise as inadequate therapy because it greatly increases the incidence of untoward reactions. In general, if definite clinical improvement is not evident within two to three days, the value of further therapy with a given antibiotic should be seriously questioned and sensitivity tests of the infecting organism should be run against this and other antibiotics before therapy is resumed.
This last statement must be qualified by a knowledge of the natural history and pathological nature of the infection. Infectious processes of soft tissues which are of short duration generally clear up quickly. Those in bone, in thrombi, and in certain other tissues require longer exposure to the antibiotic agent. It is also important to know whether the antibiotic has a bactericidal or a bacteriostatic action against the agent causing the infection. If the action is bactericidal, the therapeutic response is generally quite prompt; if bacteriostatic, the response may be slower and treatment must be more prolonged.
One final word. The indiscriminate use of antibiotics cannot be too strongly condemned. "Wholesale" treatment with a single antibiotic or "shotgun" therapy with combinations of antibiotics is bad medicine. No antibiotic, no matter how innocuous, is completely safe from the standpoint of potentially undesirable side-effects. One has only to think of the allergenicity of penicillin or the gastro-intestinal concomitants of the broad spectrum antibiotics to know that these agents are not brand names for sugar coated pink pills. And yet one is constantly aware of the fact that antibiotics are being prescribed right and left without regard to specific indications or, worse, with no indications at all.
Whatever dubious psychological advantage there may be in treating a cold with penicillin, it is surely more than offset by the fact that penicillin is totally ineffective against cold viruses at best and is a sensitizing drug to boot.
Antibiotics should prove to be of continuing value in the reduction of time lost from illness and in preventing needless deaths, if they are used with care and good judgment.
